Lemaitre Vascular Inc Quick Ratio (LMAT) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Lemaitre Vascular Inc   (NASDAQ: LMAT)

Lemaitre Vascular Inc 's Quick Ratio

LMAT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Lemaitre Vascular Inc 's Cash & cash equivalent grew by 2.45 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Lemaitre Vascular Inc 's Quick Ratio to 12.57, above Lemaitre Vascular Inc average Quick Ratio.

Within Medical Equipment & Supplies industry 8 other companies have achieved higher Quick Ratio than Lemaitre Vascular Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 427, from total ranking in the first quarter 2026 at 570.

Explain Quick Ratio?
How much Cash & cash equivalents LMAT´s has?
What are LMAT´s Current Liabilities?




LMAT Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -2.86 % 34.85 % 18.68 % 13.44 % 21.1 %
Y / Y Cash & cash equivalent Change 17.76 % 21.38 % 19.82 % 176.91 % 182.49 %
Quick Ratio MRQ 12.57 11.01 9.89 10.31 10.37
LMAT's Total Ranking # 427 # 570 # 504 # 513 # 454
Seq. Current Liabilities Change -10.29 % -8.13 % 9.12 % 8.02 % 24.53 %
Seq. Cash & cash equivalent Change 2.45 % 2.26 % 4.68 % 7.38 % 5.6 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 9
Healthcare Sector # 129
Overall Market # 379


Quick Ratio Statistics
High Average Low
14.56 3.96 0.56
(Sep 30 2011)   (Jun 30 2020)




Financial Statements
Lemaitre Vascular Inc 's Current Liabilities $ 30 Millions Visit LMAT's Balance sheet
Lemaitre Vascular Inc 's Cash & cash equivalent $ 376 Millions Visit LMAT's Balance sheet
Source of LMAT's Sales Visit LMAT's Sales by Geography


Cumulative Lemaitre Vascular Inc 's Quick Ratio

LMAT's Quick Ratio for the trailling 12 Months

LMAT Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 15.07 % 21.48 % 11.55 % 6.59 % 3.36 %
Y / Y Cash & cash equivalent TTM Growth 38.25 % 65.49 % 105.3 % 180.85 % 146.92 %
Quick Ratio TTM 10.88 10.38 10.58 10.59 9.05
Total Ranking TTM # 1505 # 1683 # 1243 # 1277 # 1298
Seq. Current Liabilities TTM Growth -0.66 % 6.89 % 4.79 % 3.41 % 4.88 %
Seq. Cash & cash equivalent TTM Growth 4.09 % 4.88 % 4.7 % 20.96 % 24.59 %


On the trailing twelve months basis LMAT Cash & cash equivalent increased by 17.76 % in Q2 2026 year on year, while Current Liabilities fell to $30 millions, this led to increase in in Lemaitre Vascular Inc 's Quick Ratio to 10.88, above LMAT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 203 other companies have achieved higher Quick Ratio than Lemaitre Vascular Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 3238.

Explain Quick Ratio?
How much Cash & cash equivalents LMAT´s has?
What are LMAT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 204
Healthcare Sector # 898
Within the Market # 427


trailing twelve months Quick Ratio Statistics
High Average Low
2.88 1.47 0.54
(Sep 30 2012)   (Jun 30 2020)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Microbot Medical Inc   34.10 $ 132.596  Millions$ 3.888  Millions
Global Innovative Platforms Inc.  31.35 $ 0.244  Millions$ 0.008  Millions
Anteris Technologies Global Corp   14.02 $ 257.385  Millions$ 18.360  Millions
Heartflow Inc   13.95 $ 615.238  Millions$ 44.088  Millions
Ceribell Inc   13.13 $ 225.898  Millions$ 17.200  Millions
Perspective Therapeutics Inc   12.80 $ 467.708  Millions$ 36.544  Millions
Lemaitre Vascular Inc   12.57 $ 376.240  Millions$ 29.935  Millions
Mobia Medical Inc   12.24 $ 177.090  Millions$ 14.472  Millions
Envveno Medical Corporation  11.39 $ 21.486  Millions$ 1.887  Millions
Pulse Biosciences Inc   9.26 $ 101.620  Millions$ 10.978  Millions
Orchestra Biomed Holdings Inc   8.16 $ 109.963  Millions$ 13.471  Millions
Biolife Solutions Inc   8.11 $ 113.100  Millions$ 13.947  Millions
Bone Biologics Corporation  7.87 $ 4.032  Millions$ 0.512  Millions
Beyond Air Inc   7.68 $ 26.340  Millions$ 3.428  Millions
Talkspace Inc   7.62 $ 90.998  Millions$ 11.937  Millions
Safe Pro Group Inc   7.24 $ 10.231  Millions$ 1.413  Millions
Delcath Systems Inc   7.22 $ 95.902  Millions$ 13.279  Millions
Streamex Corp   7.16 $ 18.586  Millions$ 2.595  Millions
Endra Life Sciences Inc  7.04 $ 5.540  Millions$ 0.787  Millions
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions

Date modified: 2026-09-11T09:47:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.